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Abstract
Introduction Injuries to the internal carotid artery close to the
cavernous sinus may result in a fistulous connection between
the artery and the venous sinus. Symptoms include pulsatile
tinnitus, intracranial bruit, ophthalmological symptoms, and
risk of intracerebral hematoma in cases of cortical venous
reflux. Previous treatment strategies have included detachable
latex balloons, coils, covered stents, or combinations thereof.
Today, detachable latex balloons are phased out or withdrawn
from several markets. Acrylic glue is a proven stable material
used for embolization of arteriovenous shunts. It is a precise,
fast, and cost-effective method of endovascular embolization,
and it does not cause artifacts on MRI or MRA.
Methods We treated nine patients suffering from direct fistu-
las with acrylic glue without any permanent neurological ad-
verse events.
Results Four patients were treated with glue embolization of
the fistula without occlusion of the parent artery. Five patients
with long-lasting symptomatology, large tears in the ICA, and
with full collateral cerebral circulation were treated with glue
embolization of the fistula and sacrifice of the ICA antero- and
retrograde via the ICA and the posterior communicating
artery.
Conclusion We suggest acrylic glue to be added to the panel
of embolic materials used to treat CCFs.
Keywords Carotico-cavernous fistula . NBCA .
Ehlers-Danlos . Collagen disease . Cavernous sinus
Abbreviations
CCA Common carotid artery
CCF Carotico-cavernous fistula
DSA Digital subtraction angiography
ECA External carotid artery
ICA Internal carotid artery
MRI Magnetic resonance imaging
MRA Magnetic resonance angiography
NBCA n-Butyl cyanoacrylate
Onyx® Ethylene vinyl copolymer and micronized tantalum
powder in dimethyl-sulfoxide (Covidien)
VA Vertebral artery
Introduction
Injuries to the internal carotid artery at or close to the cavernous
sinus may result in a fistulous connection between the artery
and the venous sinus. Symptoms created by such high-flow
carotid-cavernous fistulas (CCFs) may differ, depending on
the pattern of the venous drainage. Pulsatile tinnitus with ob-
jective intracranial bruit and ophthalmological symptoms as
exophthalmos, conjunctival hyperemia, glaucoma, oculomotor
nerve dysfunctions with diplopia, are the most frequent symp-
toms reported. Intracranial hemorrhage may occur, due to re-
flux into cortical venous contributors of the cavernous sinus
and overload and/or rupture of these venous channels.
Depending on the underlying arteriovenous connection,
carotico-cavernous fistulas have been classified in four differ-
ent groups according to Barrow et al. [1]. Type A fistulas are
direct ICA-CC fistulas following trauma or aneurysm rupture,
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whereas type B is betweenmeningeal branches of the ICA and
the cavernous sinus; type C arise from ECA branches, most
often middle meningeal or accessory meningeal arteries; and
type D have arterial supply from both ICA end ECA branches.
We will consider in this report only direct type A fistulas
arising from either trauma or spontaneous due to collagen
disease with rupture into the cavernous sinus.
As a pathological entity known since the early 1900s [2],
various treatments have been suggested for CCFs. Until the
advent of endovascular routes in the 1970–1980s, surgical sac-
rifice of the ipsilateral ICAwas most often considered standard.
The results from such ICA sacrifice are not encouraging in
modern practice; successful treatment was only achieved in
52 % of cases with mortality of almost 6 % and hemiplegia
in another 13 % [2]. Direct closure of the fistula via open
surgery was considered risky and not advisable, albeit tried
with varying results.
With the development of endovascular techniques, alterna-
tive treatments have been performed via both intraarterial and
intravenous approaches [3–7], using a variety of embolic ma-
terials, as detachable latex balloons, coils, covered stents, or
combinations of these methods. Detachable latex balloons have
been considered as the most appropriate tool to occlude a CCF
because of their safety of use and affordable price. They are
unfortunately now in limited supply and phased out or with-
drawn from several markets. Coils, covered stents, and flow
diverters are expensive methods and not always available in
low- or medium-income countries. Furthermore, the use of a
material requiring subsequent antiplatelet treatment may repre-
sent a challenge in a traumatized patient in need of emergency
treatment. There is therefore a place for other emboli: acrylic
glue is a proven stable material used for embolization of arte-
riovenous shunts since a long time and is furthermore a cheap,
fast, and cost-effective method of endovascular embolization.
Patients with collagen disease as Ehlers-Danlos syndrome
or fibromuscular dysplasia have dissection-prone vessels and
are more at risk to iatrogenic vascular injury during
endovascular surgeries [8]. Extensive endovascular procedures
requiring multiple passes and repositions of wires and catheters
may carry a prominent risk and should therefore be limited. We
share here our experience and detail the techniques used for
safe and proper treatment, and report our indications for glue
embolization. We report in this paper nine cases of
endovascular treatment of type A CCFs using acrylic glue
(Glubran® or Histoacryl®) only, resulting in successful oblit-
eration of the fistula or, when so desired, safe and permanent
closure of the ICA.
Materials and methods
We retrospectively reviewed the files of nine patients suffering
of direct CCFs referred to one of us (GR) and managed
endovascularily. These patients, average age of 35 years old
at time of surgery, range 16–86 years, 5 male and 4 female,
were included in the study (Table 1). Four patients had signs
of collagen dysplasia, out of which one had confirmed Ehlers-
Danlos disease. Five patients had suffered previous head trau-
ma. Six patients were diagnosed, treated, and followed at the
same hospital. Three patients were foreign referrals to our
center, and as such, diagnosed and followed after treatment
in their respective country of origin.
Initial radiological examination included MRI and MRA,
followed by catheter angiogram under general anesthesia at
the beginning of the treatment session. Four patients were
treated with glue embolization of the fistula without sacrifice
of the parent artery. Five patients with long-lasting symptoms,
large tears, and with an angiogram demonstrating adequate
cerebral collateral circulation were targeted for treatment with
sacrifice of the internal carotid artery.
Embolization technique
Using standard transfemoral Seldinger technique, diagnostic
angiographic workup was performed including selective in-
jections of the ICA, ECA, and VA bilaterally in standard
antero-posterior (AP) and lateral views as well as 3D rotation-
al angiography. This allowed to depict properly the localiza-
tion of the fistulous hole, the potential collateral supply to the
brain and the venous drainage pattern of the lesion.
After assessment of the anatomy and architecture of the
CCF, according to the patient’s clinical status and the length
of duration of the symptoms, it was decided to either selec-
tively occlude the fistula (if the tear in the carotid artery was
considered to be small) or to sacrifice the carotid artery
endovascularily (if the fistulous communication was large)
in patients with a long-lasting medical history of CCF and
related symptoms.
Selective occlusion of the CCF
A 6F Envoy guiding catheter (Johnson-Johnson Codman,
Raynham MA) was placed in the ICA and a microcatheter
(Magic 1.8 or Baltacci 1.8, Balt, Montmorency, France) was
inserted with the help of a microguide wire (Hybrid 008, Balt,
Montmorency, France, or Mirage 008, Microtherapeutics,
Irvine, CA) in the cavernous sinus through the fistulous com-
munication. Selective injections were performed in order to
assess the venous compartment in which the catheter was
placed. Furthermore, this allowed to test the stability of the
catheter’s position. Indeed, it was considered important to
obtain a secure position of the tip of the microcatheter, close
or against to the wall of the cavernous sinus in order to obtain
a safe deposition of glue without reflux in the parent artery.
This position of the microcatheter tip allows the first drop of
glue to stick to the wall of the cavernous sinus, avoiding any
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important spilling of glue or erratic embolus. When this could
be achieved, the microcatheter was purged with 5 % glucose,
the acrylic glue (2 cm3: Histoacryl, Braun Melsungen,
Germany, or Glubran (GEM, Viareggio, Italy) was added to
a Lipiodol (0.2 cm3: Guerbet, France) and the tantalum pow-
der (0.5 g: Balt, Montmorency, France) mixture was slowly
injected under angiographic runs at 3 frames/s within the cav-
ernous sinus compartment draining the fistula. The slight lag
in between acquisition and presentation of the runs was here
insignificant. Live road map was not used as it does not pro-
duce the same picture sharpness as a 3-fps run does. The
Glubran®: Lipiodol®mixture rapidly polymerized in the cav-
ernous sinus occluding the fistulous point from the venous
side, resulting in occlusion of the CCF. The micro- and inter-
mediate catheters were retrieved when retrograde glue reached
the tip of the microcatheter in order to avoid it to be stuck,
which never occurred in our experience. Control angiograms
were obtained in order to assess either the cure of the lesion or
the need for further embolization via the same technique. For
illustration, please see Figs. 1, 2, and 3.
Sacrifice of the ICAwith CCF
This has been performed in high-flow cases with large lacer-
ations of the carotid artery, giving rise to absence of antegrade
flow of the ICA towards the brain, vascularization of the ip-
silateral hemisphere via the contralateral ICA and the vertebral
artery through anterior and posterior communicating arteries.
In these cases, the CCF was also filled by a retrograde flow
into the supraclinoid carotid segment. It has been then decided
to occlude the shunt and the segment of the traumatized ca-
rotid artery. Using the same material for endovascular ap-
proach, the tip of the microcatheter was left in the carotid
artery close to the fistulous point: the same concentration of
glue was then injected under angiographic runs at 3 frames/s
in order to occlude both the shunt (allowing glue to penetrate
through the fistulous hole inside of the cavernous sinus) and
the carotid by reflux towards the catheter tip. The catheters
were removed when retrograde glue reached the distal end of
the microcatheter. If this embolization proved not to be cura-
tive on the control angiogram, a second glue injection was
performed after catheterization of the posterior communicat-
ing artery in the same conditions and achieved to trap the
fistula and occlude the ICA. For illustrations, please see
Figs. 4 and 5.
Fig. 1 33-year old female patient with Ehlers-Danlos syndrome and
right-sided spontaneous direct CCF, presenting with pulsatile
exophthalmus, conjunctival hyperemia and history of a right-sided
temporal hematoma. a Right ICA injection demonstrating a direct CCF
with cortical venous reflux as superior ophthalmic artery and inferior
petrosal sinus drainage. b, c: Three precise NBCA injections (two are
here shown) into the cavernous sinus at the point of drainage of the
fistula seals it shut. d Post-operative right ICA injection. The fistula is
obliterated and the ICA kept patent. No distal emboli are seen and the
cortical venous reflux is suppressed. The patient improved and
normalized after embolization.
Table 1 Patients included
Age Gender Cause Main complaint Duration of
symptoms
Technique
24 Male Unknown Bruit, ocular nerve palsy 1 year ICA sacrifice
50 Female Unknown Venous congestion, exophthalmus 3 years ICA sacrifice
25 Male Trauma Head trauma 8 months ICA sacrifice
21 Male Trauma Exophthalmus, bruit 6 years CCF closure
86 Female Unknown Exophthalmus, bruit 4 months CCF closure
33 Female Ehlers-Danlos Bruit, eye hyperemia 4 months CCF closure
16 Male Trauma Head trauma 1 month CCF closure
18 Male Trauma Head trauma 5 months ICA sacrifice
44 Female Trauma Head trauma 10 months ICA sacrifice
Nine patients, five male and four female aged 16–86 years were included. Age (years), underlying cause (if
known) of fistula, main complaint at presentation, duration of symptoms and type of treatment.
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All embolized patients were left for some days under
corticosteroids in order to reduce the inflammatory effect
related to the polymerization of the glue. No heparin was
used during or after the procedure, as we did not see
significant flow reduction in any of the adjacent veins
draining to the cavernous sinus. No intracranial adverse
advents, no permanent oculomotor nerve palsy or
ophthalmoplegia were noted at or immediately after em-
bolization. One patient (Fig. 5) presented transient sixth
nerve palsy, with only slight and short-lasting subjective
deficits, which spontaneously resolved a few days after
treatment. One patient with Ehlers-Danlos syndrome suf-
fering of spontaneous CCF had a groin hematoma at the
site of access, which did not warrant any active treatment
but compression at the puncture point.
Fig. 3 86-year old lady with a 4-month history of conjunctival
hyperemia and intracranial bruit without any known triggering factor. a
Angiogram reveals a high-flow right-sided CCF draining towards the
inferior petrosal sinus and ophthalmic veins responsible for orbital
venous congestion (d). bA targeted NBCA injection at the fistulous point
in the cavernous sinus obliterated the fistula. c 3-month post-operative
MRA demonstrating patency of the ICA and disappearance of the
pathological venous drainage. Clinical appearance of the right eye prior
to (d) and at 24-h post-embolization (e).
Fig. 2 16-year old male patient suffering a complex compound skull
base fracture after a motor vehicle accident (CT-scan, a), presenting
with 1-month history of pulsatile exophthalmus. b Initial DSA
demonstrates high-flow CCF with prominent venous hypertension. c
With a precise NBCA injection in the cavernous sinus at the fistulous
point, the CCF is closed. d Late follow-up control angiogram
demonstrating full occlusion of the CCF, patent ICA, and the classical
pouch often seen at the fistulous communication after cure. The small
residual pouch seen in panel d did not warrant further treatment.
Fig. 4 24-year old male patient with no clear head trauma recorded
presented with a year-long history of pulsatile tinnitus and right sixth
nerve palsy. a, b Preoperative MRI and MRA depicting right-sided
CCF and a dilated cavernous sinus. DSA (not shown) excluded a
ruptured intracavernous carotid aneurysm. It confirmed a CCF with a
large tear in the ICA, draining posteriorly to the inferior petrosal sinus,
with no direct supply to the ipsilateral hemisphere but adequate collateral
circulation via anterior and posterior communicating arteries. Because of
the suspicion of collagen disease and subsequent risks of balloon
manipulation, it was decided to occlude the CCF by sacrificing the
ICA. Glue injections were performed via the posterior communicating
artery (c) and the intracavernous segment of the ICA (d), which sealed the
CCF and occluded the ICA. e, f 1-month post-operative MRI and MRA
demonstrating obliteration of the fistula and ICA. The patient reported
full remission of symptoms. Note absence ofMRI/MRA imaging artifacts
after treatment with NBCA.
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Results
In this study, we treated nine patients suffering from Barrow
type A direct fistulas with acrylic glue. All nine patients had
immediate closure of the fistula at the end of the treatment
session, as intended. Four patients were treated with glue em-
bolization of the fistula without occlusion of the parent artery.
Five patients with long-lasting symptomatology, large tears in
the ICA, and with an angiogram demonstrating full collateral
circulation were treated with glue embolization of the fistula
and sacrifice of the ICA anterograde via the ICA and retro-
grade via the posterior communicating artery. One patient with
confirmed Ehlers-Danlos syndrome had a minor hematoma at
the groin site of access, however not warranting any further
clinical procedure other than follow-up. No signs of distal
embolization, cerebral ischemia, or hemorrhage were seen in
any procedure. Besides from the single case of groin hemato-
ma and the one case with transient sixth nerve palsy, no
adverse events were seen. No permanent oculomotor deficits
were noted.
Six patients had an angiogram and/or MRI/MRA at 2 to
6months after treatment, all without any signs of recurrence or
recanalization of the fistulous lesion. Imaging artifacts on
MRI from the glue/tantalum injections were absent (Figs. 3,
4 and 5). All patients reported significant improvement of
clinical symptoms with regression of eye symptoms and/or
decreased or absent cranial bruit. Three referred foreign pa-
tients had clinical follow-up in their respective country of
origin and to date, no reports of recurrence or adverse events
have been communicated to the authors.
Discussion
Treatment of CCFs has evolved considerably from the first
treatment reported in 1809when ligation of the CCAwas done
[2]. Sacrifice of the ICAwas one of the first reported strategies
for CCF, and the methodmay still be considered as a treatment
modality in selected rare cases [2, 9].
The first reports of modern endovascular treatment for
CCFs were in the early 1970s by using detachable latex bal-
loons [10]. Endovascular treatment modalities evolved with
the advent of detachable coils in the 1990s and was developed
further with stents, Onyx, and off-label use of vascular plugs
until present day. Although used for other arteriovenous fistu-
las, radiosurgery was never a good option for high-flow CCFs
but has in some centers held an adjunct treatment modality for
low-flow Barrow B-D type fistulas [2, 9, 11].
Detachable latex balloons, previously the mainstay in treat-
ment of CCF, are easy to maneuver, affordable, and supple to
use with advantages in wall remodeling close to the fistula.
However, despite these positive advantages, latex balloons are
now being progressively phased out and withdrawn and no
longer accessible in all markets. Albeit still accessible in lim-
ited supply, the balloonsmay deflate over time and themethod
sometimes calls for additional coiling and/or injection of em-
bolic material like Onyx or NBCA [4, 12]. Latex balloons
cannot be combined with the here-described glue emboliza-
tion technique, as glue will cause the balloon to rupture. Latex
is also a material which in some individuals may cause allergic
reactions, limiting its use in such cases.
Direct coiling, balloon- or stent-assisted coiling are nowa-
days techniques readily available in most neurointerventional
centers. The technique is previously described [3] and will in
most cases be sufficient, and is advocated in cases of aneurys-
mal rupture as underlying cause for the CC-fistula. However,
coil compaction with subsequent risk of recanalization still
constitutes a caveat to this technique. Coiling of the cavernous
sinus may be done both from the arterial and venous route.
The latter has often been used in indirect dural fistulas via the
inferior petrosal sinus, superior petrosal sinus, facial veins, or
Fig. 5 50-year old female patient without previous history of head
trauma presented with 3-year history of secondary orbital and facial
venous congestion (a) related to a left-sided high-flow CCF draining
towards the superior ophthalmic vein, as superficial and deep cortical
veins (b). Left vertebral artery injection (c) and left internal carotid
artery injection (d) confirmed the fistulous communication. Because of
the suspicion of underlying collagen disease and the risks of balloon
manipulation, the circulation to the ipsilateral hemisphere being brought
by collateral circulation, it was decided to sacrifice the carotid artery and
occlude the fistula by glue injections via the internal carotid (e) and the
posterior communicating arteries (not shown). f: post-operative MRA
24 h after embolization confirmed obliteration of the fistula and ICA
with collateral flow to the left hemisphere via the anterior
communicating artery. g Orbital and facial venous dilatations resolved
after treatment (clinical appearance 5-day post-embolization), a slight
6th nerve palsy was present, which fully resolved after a few additional
days.
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the superior ophthalmic vein [13, 14], having demonstrated
obliteration rates up to 90% [14]. Direct fistulas from the ICA
to the cavernous sinus can also be approached and treated
transvenously. The technique may be considered if the arterial
route is inaccessible or considered complicated, for example
in Ehlers-Danlos patients [15].
Flow diverters and covered stents have gained interest as
devices suitable to treat CCFs [16, 17]. However, besides being
expensive, they require antiplatelet treatment for at least 3–
6months, sometimes life-long, with subsequent risk of adverse
events before the device is endothelialized. These devices may
by some centers be considered as first-line treatment, however
not without caveats. Any antiplatelet regimen is risky in pa-
tients with recent multitraumas with or without traumatic brain
injury. Also, there have been reports of failure of covered stents
resulting in induced fistulas requiring additional treatment with
Onyx [18]. Onyx is another liquid embolus and could be used
for similar managements. We do not have any experience with
this material in these diseases and therefore cannot comment
further properly about its position in treatment of these fistulas.
Abstaining from implantable devices and Onyx may in addi-
tion also result in less imaging artifacts later on, which is a
factor to consider when follow-up is planned in a center not
having access to Vaso-CT or Dyna-CT.
Stemming from experience in treatment of high-flow AVMs
and other intracranial fistulas, glue has had a proven treatment
record and is today still used to treat these lesions successfully
[8]. A CCF is a skull base arteriovenous fistula and could there-
fore be approached using the same methodology. As for any
other AV shunt, pre-therapeutic precise analysis of the regional
and lesion anatomy is warranted. The cavernous sinus is ana-
tomically not a sinus proper; it closely resembles a venous
plexus where different compartments are separated by thin
walls and trabecles [8, 19]. A CCF thus usually drains into
one of the compartments and occlusion of that precise compart-
ment will not create occlusion of the whole cavernous sinus. It
may remain patent and continue to drain the brain properly after
embolization. Therefore, the venous compartment draining the
CCF and the brain have thus to be recognized and understood
so that selective occlusion of the former can be properly
achieved without impairing the latter. This also explains why
permanent ophthalmological deficits rarely are seen after glue
injection into the cavernous sinus. The inflammatory effect of
the polymerizing glue as sudden changes in venous drainages
(sludge and thrombosis) may however cause transient nerve
palsies, as seen in the case in Fig. 5, which normally regress
within a few weeks under steroid therapy.
The arterial side, the ICA, also needs special attention, and
the understanding of the architecture of the fistulous commu-
nication is important for proper therapeutic management
(whatever the technique used). Using glue to close CCF rep-
resents a crucial moment when the fistula closes, as the flow
could be directed into the still patent ICA with risk of distal
glue embolization with possible detrimental consequences
[17]. It is the reason why we have chosen to inject the glue
under angiographic runs at 3 frames/s so that precise visuali-
zation of the glue can be obtained.
Should there be a large-size fistula and given that adequate
perfusion of the ipsilateral hemisphere may be provided via
patent collateral circulation, endovascular sacrifice if the ICA
can be considered. Previously, sacrifice was made via CCA or
ICA ligation, which was followed by detachable latex balloons
or off-label use of Amplatzer vascular plugs [12] if needed.
However, detachable latex balloons have been reported to man-
age to preserve the patency of the ICA in about 70 % of cases
[8]. The five cases of our series show that proper injections of
glue in the ICA can result in sacrifice of the internal carotid
artery and occlude the CCF, with minimal risk of adverse distal
embolization and no noted recanalization. We believe this ap-
proach with supple microcatheters and glue can be considered
as an alternative to techniques using comparably stiffer
microcatheters for coils and stents. The proposed technique
may also be done from the contralateral ICA via a patent ante-
rior communicating artery or via the vertebrobasilar circulation
and the posterior communicating artery, which may be of in-
terest if the proximal ICA for any reason is inaccessible [20].
Although not within the scope of the present report, one
may also combine glue injections with coiling by first placing
coils and then occluding the fistula with glue. This approach
may facilitate glue injection, thanks to the reduction of the
flow obtained with coils [6].
In cases of known connective tissue disease with higher
risk of iatrogenic injuries, for instance in Ehlers-Danlos syn-
drome with elevated risk of CCF [21, 22], special care must be
taken to insure a safe endovascular procedure. Some centers
may still advocate open surgery for these patients, and there
have been reports of combinatorial approaches with surgical
exposure of the cavernous sinus followed by direct insertion
of endovascular sheaths and embolization [23]. In order to
avoid accidental dissections, rapid and less traumatic tech-
niques are here advisable as we seek to limit both the amount
of hardware and the duration of endovascular intervention in
cases of spontaneous CCFs. Balloons require inflation, defla-
tion, and detachment with pulling on the catheters, all risks of
further damage to the ICA. Coils may require multiple repo-
sitions of the catheter and several catheterizations of the fistula
if kickback of the catheter occurs during coil deployment—all
adding risks to the carotid wall. As the described technique
only requires a minimum of catheter manipulations, prefera-
bly a precisely placed supple flow-directed microcatheter such
as the here-employed Magic® and almost instantaneous oc-
clusion of the fistula with precise injection of glue, we believe
this approach as safe in regards to accidental preoperative
dissection, however of course not without such risk. Here,
we report one successfully treated CCF in an Ehlers-Danlos
patient with glue embolization.
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Today, endovascular devices are still expensive and the
cost of hardware is an ever-present factor in any clinical prac-
tice and also limits the use of neurointerventional strategies in
low-income settings. Glue embolization could be of value as
less costly treatment method in both developing economies as
in any modern hospital setting. We believe the method pre-
sented here, if used by experienced interventional neuroradi-
ologists, is as safe and efficient as any device-driven modality.
Previous experience from glue embolization of fistulas or
AVMs is a prerequisite and not having necessary knowledge
constitutes a limitation of the technique in the interest of
safe medical practice.
The methods here presented are novel use of classical
techniques, using proven methodology and materials.
We demonstrate adequate closure of Barrow type A fis-
tulas without any permanent neurological adverse
events. In all, we suggest that, when properly used, glue
can be added to the panel of embolic materials used to
treat CCFs.
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